Brief: ASIT Biotech Gives Update On GP-ASIT+

European Medical Solutions SA

31/01/2019 06:08

Jan 31 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * FIRST PATIENT TREATED WITH GP-ASIT+™ WITHIN THE FRAMEWORK
OF THE
CONFIRMATORY PHASE III STUDY IN GRASS POLLEN RHINITIS
    * THIS INCLUSION RATE IS IN LINE WITH OBJECTIVE OF TREATING
624
PATIENTS ACROSS 6 EUROPEAN COUNTRIES BEFORE START OF POLLEN
SEASON
    * LAST-PATIENT-LAST-VISIT IS SCHEDULED FOR Q3 OF 2019
    * RESULTS COULD BE AVAILABLE BY DECEMBER 2019

Source text for Eikon:  ID:nBw58j0zTa 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))